There are three possible explanations for the results of this study: (1) the association between visfatin itself and metabolism-related diseases is relatively weak; (2) different population sources and study designs can influence results; and (3) the sample size of this study was not sufficiently large. The gene discussed is NAMPT; the disease is glycogen storage disease VI.